In the age of Ozempic, who gets it and who pays?
In the Age of Ozempic: Accessibility and Cost The effectiveness and cost of weight loss drugs like Ozempic, Wegovy, and Mounjaro have been discussed on "Connections with Evan Dawson". …
Brand-new Toronto transit station is finally about to open
New Toronto Transit Station to Open A new station serving GO Transit's Kitchener Line and UP Express is set to open in weeks. Metro…
Valence-based Dracula Technologies secures €30M in Series A round to power IoT devices with light instead of batteries - Silicon Canals
Dracula Technologies Secures €30M in Series A Round Valence, France-based Dracula Technologies has announced the successful completion of …
Which Non-League sides will take part in the Isuzu FA Trophy Second Round Proper? - The Non-League Football Paper
Isuzu FA Trophy Second Round Proper Draw Confirmed The draw for the Isuzu FA Trophy Second Round Proper has been announced, with 40 matche…
Study Claims Ozempic Lowers Biological Age | PharmExec
Study Claims Ozempic Lowers Biological Age Researchers reveal that GLP-1 medication Ozempic may reduce biological age, offering new hope i…
World Treadmill Champs will be staged over 5km in 2026 - Athletics Weekly
World Treadmill Championships to Debut in 2026 The first-ever World Treadmill Championships, dubbed RUN X, will take place over 5km in 202…
Food Ingredients Europe set for key return in Paris - Confectionery Production
Fi Europe 2025: A Key Return to Paris Registration is now open for Fi Europe 2025, celebrating its 30th edition in Paris from 2-4 December…
How to Navigate Complex Injury Cases Efficiently - GigWise
Navigating Complex Injury Cases Dealing with a serious injury case can be stressful and confusing, with nearly 70 percent of personal inju…
Kymera Therapeutics, Inc.: Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting
Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc. announced the presentation of new preclinical data …
Designing Light-Filled Living Spaces: How Lifestyle Remodeling Is Shaping the Future of Tampa Sunrooms
Designing Light-Filled Living Spaces In Florida, natural light is one of the state’s most abundant resources—and homeowners are increasing…
Neumora Therapeutics, Inc.: Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 single-ascending do…